FDA NDC Directory · JSON-LD · Markdown

Tecentriq Hybreza

NDC 50242-933 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameatezolizumab and hyaluronidase-tqjs
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761347
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsATEZOLIZUMAB (1875 mg/15mL)
HYALURONIDASE (HUMAN RECOMBINANT) (30000 U/15mL)
Marketing started20240912
Package count2

External sources

Source: openFDA. Public-domain (CC0).